Even though this could not be confirmed in this case, the MHC-II-positive tumors displayed a significant CD4+ T lymphocyte infiltration, suggesting the involvement of an MHC-II-restricted CD4+ TH cell activation against tumor antigens. This evidence concerns the gene CD4 and neoplasm.